US To Acquire Anthrax Drug From Cangene
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on July 28, 2006
In June the US government has agreed to purchase 20,000 doses of ABthraxâ„¢ from Human Genome Sciences. But the stockpiling of drugs against inhalational anthrax, a potential bioweapon causing an acute infectious disease resulting from inhaling spores of Bacillus anthracis, is not yet over. Still under the Project BioShield Act of 2004, the U.S. Department of Health and Human Services will acquire an additional 10,000 doses of anthrax immune globulin (AIG) for $143 million, this time from Cangene.
More information about AIG and the supply contract from Cangene's press release.
Permalink: US To Acquire Anthrax Drug From Cangene
Tags: anthrax bioweapon biotech cangene acquire acquire+anthrax anthrax+drug stem+cells
Vote for US To Acquire Anthrax Drug From Cangene:
|
Rating: 8.67 out of 3 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells